Olympiad Research’s Usana Health Sciences USNA Stock Holding History

Olympiad Research’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,104	Closed	-$228K	–	450
2020 Q2	$228K	Buy	+3,104	New	+$243K	0.16%	189

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Olympiad Research's USNA Position: Q3 2020 in Review

Olympiad Research sold out of Usana Health Sciences (USNA) in Q3 2020, closing a stake of 3,104 shares — an estimated $228K sold.

Olympiad Research first reported a position in USNA in Q2 2020 and held it in 1 quarter. The position peaked at $228K in Q2 2020. 192 funds tracked by Wall St. Rank hold USNA as of Q3 2020.

Olympiad Research reported no remaining Usana Health Sciences position as of Q3 2020 after selling out during the quarter.
Olympiad Research sold 3,104 Usana Health Sciences shares in Q3 2020, an estimated $228K.
Olympiad Research first reported a position in Usana Health Sciences in Q2 2020 and held it in 1 quarter.
Olympiad Research's Usana Health Sciences position peaked at $228K in Q2 2020.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2020.

Based on Olympiad Research's 13F filing for Q3 2020, filed 2 Nov 2020.